Stereotactic MR-guided adaptive radiotherapy (SMART) for primary rectal cancer: evaluation of early toxicity and pathological response.
Alessandra CastellucciaDomenico MarchesanoGianmarco GrimaldiIvan AnnessiFederico BianciardiCristian BorrazzoAnnamaria DipalmaRanda El GawharyMarica MasiMaria RagoMaria ValentinoLaura VernaMaurizio PortaluriPierCarlo GentilePublished in: Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology (2023)
To our knowledge, this is the first study to use stereotactic radiotherapy for primary rectal cancer. SMART for rectal cancer is well tolerated and effective in terms of tumor regression, especially if followed by delayed surgery.